This suggests that upon TB treatment, differentiated Th17-like CD4+ subsets expressing high levels of CD26 and IL7Ra are enriched in peripheral blood, likely at the expense of less differentiated subsets expressing high levels of CD27 and CD38. The gene discussed is CD38; the disease is tuberculosis.